Cent Eur J Public Health 2019, 27(Supplement):S6-S9 | DOI: 10.21101/cejph.a5998

Alcohol and cardiovascular disease: Position Paper of the Czech Society of Cardiology

Renata Cífková1,2, Alena Krajčoviechová1
1 Centre for Cardiovascular Prevention, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
2 Department of Medicine II, First Faculty of Medicine, Charles University, Prague, Czech Republic

Epidemiologic studies consistently report a U-shaped curve relationship between the amount of alcohol consumption and cardiovascular disease, with consumption of ≥ three alcoholic drinks being associated with an increased risk. However, the cardioprotective effect of light and moderate alcohol consumption has been recently questioned. In the absence of a randomized trial confirming the cardioprotective effect of light or moderate alcohol consumption, an alternative method to prove the causality is Mendelian randomization using a genetic variant serving as a proxy for alcohol consumption. A Mendelian randomization analysis by Holmes et al. suggests that a reduction in alcohol intake is beneficial for cardiovascular health also in light to moderate drinkers. In a recent analysis of 83 prospective studies, alcohol consumption was roughly linearly associated with a higher risk of stroke, coronary heart disease excluding myocardial infarction, heart failure and risk of death from aortic aneurysm dissection. By contrast, increased alcohol consumption was associated with a lower risk of myocardial infarction. "Low-risk" alcohol consumption recommended by the National Institute of Public Health, Czech Republic, should not exceed 16 g of 100% ethanol/day for women and 24 g/day for men; at least two days a week should be alcohol free, and the dose of ethanol during binge drinking should not exceed 40 g. In practice, this means one standard drink daily for five days at most and two standard drinks at most when binge drinking. These amounts should be considered the highest acceptable limits, but alcohol consumption in general should be discouraged.

Klíčová slova: cardioprotective effect of alcohol, alcohol consumption, Mendelian randomization, heavy drinking, moderate drinking, light drinking

Vloženo: 12. říjen 2019; Revidováno: 21. listopad 2019; Přijato: 21. listopad 2019; Zveřejněno: 31. prosinec 2019  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cífková R, Krajčoviechová A. Alcohol and cardiovascular disease: Position Paper of the Czech Society of Cardiology. Cent Eur J Public Health. 2019;27(Supplement):S6-9. doi: 10.21101/cejph.a5998. PubMed PMID: 31901187.
Stáhnout citaci

Reference

  1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671. doi: 10.1136/bmj.d671. Přejít k původnímu zdroji... Přejít na PubMed...
  2. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817-43. Přejít k původnímu zdroji... Přejít na PubMed...
  3. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2(8623):1267-73. Přejít k původnímu zdroji... Přejít na PubMed...
  4. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011 Feb 22;342:d636. doi: 10.1136/bmj.d636. Přejít k původnímu zdroji... Přejít na PubMed...
  5. Bennett DA, Holmes MV. Mendelian randomisation in cardiovascular research: an introduction for clinicians. Heart. 2017;103(18):1400-7. Přejít k původnímu zdroji... Přejít na PubMed...
  6. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health. 2007;30(1):5-13.
  7. Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164. doi: 10.1136/bmj.g4164. Přejít k původnímu zdroji... Přejít na PubMed...
  8. Wood AM, Kaptoge S, Butterworth AS, Willeit P, Warnakula S, Bolton T, et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet. 2018;391(10129):1513-23. Přejít k původnímu zdroji... Přejít na PubMed...
  9. Ruprich J, editor. An overview of national guidances for moderate consumption of alcoholic beverages: low-risk ethanol doses. Brno: NIPH; 2015.
  10. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81. Přejít k původnímu zdroji... Přejít na PubMed...